David Daokui Li
Li Daokui (Chinese: 李稻葵; pinyin: Lǐ Dàokúi; born 22 December 1963) is a Chinese economist and the Mansfield Freeman Professor of Economics and director of the Center for China in the World Economy (CCWE) at Tsinghua University's School of Economics and Management (SEM), where he teaches courses on economic transition, corporate finance, international economics, and China's economy. In 2013, Li was appointed the founding dean of the Schwarzman Scholars program at Tsinghua.[1][2]
Li Daokui | |
---|---|
李稻葵 | |
Born | Beijing, China | December 22, 1963
Nationality | Chinese |
Education | Harvard University (PhD - Economics) |
Children | 2 |
Li Daokui is a part of an academic trio that replaced Fan Gang to the Monetary Policy Committee of the People's Bank of China (PBOC), China's central bank.[3] He is a former member of the Chinese People's Political Consultative Conference.[2]
Career
Li has held numerous positions in academia. These include a visiting scholarship at the Center for International Development (CID) of the Harvard Kennedy School (1986), assistant professor at the University of Michigan-Ann Arbor, research fellow at the Hoover Institute of Stanford University, and professor and deputy director of the Economic Development Research Center of Hong Kong University of Science and Technology.
Li has also served as the editor for the Journal of Comparative Economics from 2000 to 2003 and the Economics Bulletin. He returned to China in 2004 to teach at his alma mater, Tsinghua, and to serve as head of the Center for China in the World Economy research center.
From 2016 to 2018, Li was a member of the monetary policy committee of China's central bank.[4] He was succeeded by Dingo Xu on the board of JD.com in 2018.[5] In 2018, he presented for the Academic Center for Chinese Economic Practice and Thinking (ACCEPT) a report by titled "Economic Lessons Learned from China's Forty Years of Reform and Opening-Up".[6] He has written op-eds for The Wall Street Journal on topics like the Asia Infrastructure Investment Bank.[7]
In August 2020, Li stated China could restrict exports of medicine to the U.S. in response to American technology export restrictions on China.[8]
References
- Bradsher, Keith (2013-04-20). "$300 Million Scholarship for Study in China Signals a New Focus". The New York Times. ISSN 0362-4331. Archived from the original on 2019-11-06. Retrieved 2020-08-27.
- Allen-Ebrahimian, Bethany (January 11, 2020). "The Moral Hazard of Dealing With China: Academic institutions must grapple with the question of when engagement becomes complicity". The Atlantic. Archived from the original on 15 January 2020. Retrieved 27 August 2020.
- "China Names Three Economists to PBOC Monetary Policy Committee" March 29, 2010, Bloomberg
- Keith Bradsher (August 12, 2016). "Trillions in Murky Investments Could Rock China's Economy". The New York Times. Retrieved October 6, 2020 – via www.nytimes.com.
- Prachi Singh (May 22, 2018). "Professor Dingbo Xu appointed to JD.com's board of directors". www.fashionunited.com. Fashion United. Retrieved May 22, 2018.
- "Experience over past four decades gives optimism for the future". www.chinadaily.com. China Daily. December 11, 2018. Retrieved October 6, 2020.
- David Daokui Li (March 30, 2015). "A Powerful Message From America's Frustrated Allies". The Wall Street Journal. Retrieved October 6, 2020 – via www.wsj.com.
- Zhou, Cissy (26 August 2020). "China could weaponise drug exports to retaliate against US chip restrictions, Beijing adviser says". South China Morning Post. Archived from the original on 27 August 2020. Retrieved 27 August 2020.